Welcome to the TAVR Lifecycle Optimization Calculator
Total sessions
Active improvement initiatives
Documents created
Patients tracked
3M-TAVR Study (Butala et al., 2022)
$11,305 savings per patient with minimalist approach
PARTNER 3 Trial
Target LOS of 1.6 days achievable with optimization
Target AS Study
35% mortality reduction with treatment vs. watchful waiting